Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Step-Up Syrup is a marketed pharmaceutical formulation developed by **Emcee Pharmaceuticals**, primarily used as an appetite stimulant and growth promoter. It is a combination therapy typically containing **cyproheptadine hydrochloride** and **tricholine citrate**. Cyproheptadine is a first-generation antihistamine with additional antiserotonergic properties; it acts as an antagonist at serotonin receptors in the hypothalamus, which is believed to stimulate the appetite center. Tricholine citrate serves as a lipotropic agent that helps in the depletion of fat levels in the liver and supports hepatobiliary function. The syrup is indicated for the treatment of loss of appetite, weight loss, growth failure, and convalescence following hepatitic disorders, particularly in pediatric populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Step-Up Syrup.